The EF-hand calcium binding domain 12 (EFHD2) protein is characterized by its EF-hand motif, a helix-loop-helix structural domain that can bind calcium ions with high affinity. The EF-hand domain is a common feature in calcium-binding proteins and plays a crucial role in translating calcium signals into cellular responses.EFHD2 is involved in various cellular processes, including signal transduction, cell motility, and apoptosis, which are heavily influenced by calcium signaling. Calcium ions serve as a universal second messenger in numerous signal transduction pathways, and proteins like EFHD2 are pivotal in mediating the physiological responses to changes in intracellular calcium levels.
The specific functions of EFHD2 are associated with its ability to bind calcium and undergo conformational changes that enable it to interact with and regulate other proteins. This can lead to the activation or inhibition of signaling pathways that are essential for cellular homeostasis, growth, and differentiation. For example, EFHD2 has been implicated in the modulation of the cytoskeleton, which is integral to cell shape and motility, as well as in synaptic plasticity, which is essential for learning and memory in neurons.Research into EFHD2 may explore its role in neurodegenerative diseases, as alterations in calcium homeostasis and signaling are often linked to conditions such as Alzheimer's disease and Parkinson's disease. Additionally, understanding EFHD2's function in apoptosis may provide insights into cancer biology, as dysregulated apoptosis is a hallmark of cancerous cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that inhibits L-type calcium channels, reducing calcium influx into cells, potentially affecting EF-hand domain protein function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another L-type calcium channel blocker, it decreases intracellular calcium levels, indirectly influencing EF-hand domain-containing proteins. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Ryanodine receptor antagonist that inhibits calcium release from the sarcoplasmic reticulum, affecting calcium-dependent processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor, it leads to increased cytosolic calcium levels, indirectly impacting proteins with EF-hand domains. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
An IP3 receptor inhibitor, it modulates calcium release from intracellular stores, affecting calcium-mediated signaling. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
A selective ryanodine receptor modulator, it alters calcium release from sarcoplasmic and endoplasmic reticulum. | ||||||
Carbetocin | 37025-55-1 | sc-504618 | 10 mg | $330.00 | ||
An inhibitor of intracellular calcium release, it modulates calcium signaling pathways. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
A calcium channel blocker with effects on both L-type and T-type channels, altering calcium dynamics. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
A long-acting calcium channel blocker, primarily affecting L-type channels and calcium homeostasis. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
A calcium channel blocker with specificity for cerebral arteries, influencing calcium signaling in the brain. | ||||||